PER genes are deregulated at many levels in cancer, such as altered methylation of PER1 and PER2 promoter (195, 196) and increased expression, for example, in prostate cancer, as PER1 is regulated by androgen receptor signaling (197). This evidence concerns the gene PER2 and cancer.